Investor Overview

Investor Presentation
Financial News
Nov 13, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today reported financial results for the three and six months ended...

Nov 8, 2018

/NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES./ TORONTO and HOUSTON, TX, Nov. 8, 2018 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company"

Nov 7, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, will be presenting an update on previously announced data from the...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Friday, November 16, 2018
7:30pm - 9:30pm EST

Presenter: Dr. Achal Singh Achrol, MD; Director of the Neurosurgery Clinical Trials Program and Chief of the Glioma Surgery Program at the John Wayne Cancer Institute and Pacific Neuroscience...

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
Mike Cole, MZ Group 
1-949-259-4988
Email Alerts
* Required Fields